These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18972750)

  • 21. [Relationship of clinicopathological features and chemotherapeutic outcomes in women with BRCA1 and BRCA2 mutation-negative familial breast cancer].
    Zhang J; Sun J; Ouyang T; Li JF; Wang TF; Fan ZQ; Fan T; Lin BY; Xie YT
    Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):185-9. PubMed ID: 26988823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer.
    Cox DG; Kraft P; Hankinson SE; Hunter DJ
    Breast Cancer Res; 2005; 7(2):R171-5. PubMed ID: 15743496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance.
    Skol AD; Sasaki MM; Onel K
    Breast Cancer Res; 2016 Oct; 18(1):99. PubMed ID: 27716388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
    Tonin PN
    Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer susceptibility genes. BRCA1 and BRCA2.
    Brody LC; Biesecker BB
    Medicine (Baltimore); 1998 May; 77(3):208-26. PubMed ID: 9653432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction.
    Jones MR; Kamara D; Karlan BY; Pharoah PDP; Gayther SA
    Gynecol Oncol; 2017 Dec; 147(3):705-713. PubMed ID: 29054568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
    Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL
    J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer.
    Chappuis PO; Nethercot V; Foulkes WD
    Semin Surg Oncol; 2000 Jun; 18(4):287-95. PubMed ID: 10805950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families.
    Osorio A; Barroso A; Martínez B; Cebrián A; San Román JM; Lobo F; Robledo M; Benítez J
    Br J Cancer; 2000 Apr; 82(7):1266-70. PubMed ID: 10755399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of next generation sequencing on the analysis of breast cancer susceptibility: a role for extremely rare genetic variation?
    Hilbers FS; Vreeswijk MP; van Asperen CJ; Devilee P
    Clin Genet; 2013 Nov; 84(5):407-14. PubMed ID: 24025038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of genetic variations in miRNA-binding sites of BRCA1 and BRCA2 genes as risk factors for the development of early-onset and/or familial breast cancer.
    Erturk E; Cecener G; Polatkan V; Gokgoz S; Egeli U; Tunca B; Tezcan G; Demirdogen E; Ak S; Tasdelen I
    Asian Pac J Cancer Prev; 2014; 15(19):8319-24. PubMed ID: 25339023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
    Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
    Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk.
    Freedman ML; Penney KL; Stram DO; Riley S; McKean-Cowdin R; Le Marchand L; Altshuler D; Haiman CA
    Cancer Res; 2005 Aug; 65(16):7516-22. PubMed ID: 16103107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can unknown predisposition in familial breast cancer be family-specific?
    Lynch H; Wen H; Kim YC; Snyder C; Kinarsky Y; Chen PX; Xiao F; Goldgar D; Cowan KH; Wang SM
    Breast J; 2013; 19(5):520-8. PubMed ID: 23800003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
    Walsh T; Casadei S; Coats KH; Swisher E; Stray SM; Higgins J; Roach KC; Mandell J; Lee MK; Ciernikova S; Foretova L; Soucek P; King MC
    JAMA; 2006 Mar; 295(12):1379-88. PubMed ID: 16551709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The BARD1 Cys557Ser variant and breast cancer risk in Iceland.
    Stacey SN; Sulem P; Johannsson OT; Helgason A; Gudmundsson J; Kostic JP; Kristjansson K; Jonsdottir T; Sigurdsson H; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Bergthorsson JT; Amundadottir LT; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K
    PLoS Med; 2006 Jul; 3(7):e217. PubMed ID: 16768547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide association study of susceptibility loci for breast cancer in Sardinian population.
    Palomba G; Loi A; Porcu E; Cossu A; Zara I; Budroni M; Dei M; Lai S; Mulas A; Olmeo N; Ionta MT; Atzori F; Cuccuru G; Pitzalis M; Zoledziewska M; Olla N; Lovicu M; Pisano M; Abecasis GR; Uda M; Tanda F; Michailidou K; Easton DF; Chanock SJ; Hoover RN; Hunter DJ; Schlessinger D; Sanna S; Crisponi L; Palmieri G
    BMC Cancer; 2015 May; 15():383. PubMed ID: 25956309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BRCA1 and BRCA2 in breast cancer.
    Yang X; Lippman ME
    Breast Cancer Res Treat; 1999 Mar; 54(1):1-10. PubMed ID: 10369075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer families.
    Li J; Li H; Makunin I; ; Thompson BA; Tao K; Young EL; Lopez J; Camp NJ; Tavtigian SV; John EM; Andrulis IL; Khanna KK; Goldgar D; Chenevix-Trench G
    Breast Cancer Res Treat; 2017 Dec; 166(3):937-949. PubMed ID: 28840378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.